Ketamine Therapy for Depression in Older Adults: Complete Guide

You stare at the pill organizer and wonder how many more medication changes you're supposed to endure before something helps. If you're the one struggling, or the adult child arranging rides and worrying about falls and whether another treatment is worth the strain, the decision can feel exhausting.

Depression affects more than 21 million U.S. adults a year, and standard antidepressants don't help everyone. For older adults who have already cycled through several medications, ketamine therapy offers a new approach that works through the brain's glutamate system rather than serotonin, and its at-home form can fit daily life better than repeated clinic visits.

The bottom line: Ketamine may help some older adults whose depression hasn't responded to other treatments, but the evidence is mixed. The one dedicated trial in people 65 and older didn't meet its main goal, though those aged 65 to 74 and people whose depression began earlier in life did improve. Safety screening matters more with age, and a monitored at-home model can be more practical than repeated clinic trips.

How does ketamine therapy work for older adults?

Ketamine works differently from traditional antidepressants. It first blocks N-methyl-D-aspartate (NMDA) receptors, the brain's switches for learning and memory, on certain inhibitory brain cells. That sets off a surge of glutamate, the brain's main activating chemical, in the prefrontal cortex.

The glutamate surge then triggers the release of brain-derived neurotrophic factor (BDNF), a protein that supports new synapses. Within hours, the brain can start rebuilding connections, and those gains in neuroplasticity may last a week or more as it restores communication between the regions that regulate mood.

This route matters more with age: older brains make less BDNF and lose connections over time, and because ketamine bypasses the depleted serotonin system, it targets brain repair along a different path.

What does the research show for older adults specifically?

The clearest test came from TRANSFORM-3, a 2019 Phase 3 trial built for people aged 65 and older. It tested intranasal esketamine (Spravato) in 138 patients with treatment-resistant depression, and the main result did not reach statistical significance. In subgroup analysis, though, people aged 65 to 74 improved meaningfully, those 75 and older showed little measurable benefit, and people whose depression started before age 55 responded better than those with later onset.

Other studies are smaller and more preliminary. In one analysis, IV ketamine produced a 48% response rate in older adults, and a small subcutaneous trial reported that 68.8% of older participants reached remission at least once, with half holding it for a week. A 2026 systematic review of 13 studies and 757 adults aged 60 and older called the picture mixed, with only preliminary signs of improvement.

One caveat ties this together. The studies above used IV infusions or the intranasal spray, while Innerwell prescribes sublingual ketamine taken at home, an off-label use for depression.

Real-world data on the sublingual form show it can be effective and well tolerated in adults, but it hasn't been studied specifically in older adults. That gap is why careful screening and conservative dosing matter here, and why any single number above is best read as a signal rather than a promise.

What does improvement actually look like?

Clinical trials measure progress as points dropped on a depression scale, which says little about an ordinary day. People more often describe it as the volume turning down. The morning dread eases enough to get out of bed without a fight. A call with a grandchild feels like connection again rather than effort. It's closer to the quiet return of "okay" than to a rush of happiness.

What are the risks of ketamine therapy for older adults?

Most side effects during a session are short-lived. Dissociation, nausea, and dizziness usually fade within two hours. Older adults often feel these effects more strongly because their bodies clear the drug slowly, so they usually need lower doses.

The main age-specific concern is cardiovascular. In the dedicated geriatric study, about 17% experienced a systolic blood-pressure spike of at least 40 mmHg during treatment, compared with roughly 8% of adults in the broader trials.

Ketamine isn't appropriate for anyone in whom a sharp rise in blood pressure would be hazardous, such as people with certain blood-vessel problems or a history of bleeding in the brain, all of which become more common with age.

Fall risk pulls in the same direction. Dizziness, sedation, and slower metabolism are a real hazard for someone already unsteady or on other medications, and you won't be able to drive until the next day.

Drug interactions deserve close attention, given the long medication lists common at this age. Benzodiazepines and opioids both add to ketamine's sedative effects, which is what the intake evaluation is built to catch.

Comparing ketamine options for older adults

The options differ most in where you go, who monitors you, and what they cost

For many older adults, the at-home route removes the biggest barrier, repeated clinic trips, while the forms with the most direct elderly research are clinic-based. Your evaluation sorts out that trade-off.

How Innerwell's at-home ketamine therapy works for older adults

You don't have to figure this out alone. Ketamine can open a door; the therapy around it is what helps you walk through. It works best paired with preparation before each session and integration afterward, the piece a medication-only service leaves out. Innerwell's at-home ketamine therapy program is built around that support, for older adults and their families.

The process:

1. Evaluation with age-specific screening. You start with a virtual psychiatric assessment that goes beyond a standard intake. Specialists review cardiovascular health, cognitive status, and medication interactions, then coordinate with your primary care doctor or cardiologist before clearing you for treatment.
2. Secure medication delivery. Once cleared, you receive sublingual ketamine tablets from a licensed pharmacy, with conservative dosing instructions and direct access to the care team through secure messaging.
3. Guided preparation and integration therapy. Licensed therapists guide you in setting intentions before each session and help you process what comes up afterward, when the brain may be especially open to change. Caregivers can learn to help and track progress, and Innerwell's guide on how to prepare walks through what to expect.
4. Monitoring and specialist coordination. The team tracks progress through clinical check-ins, blood-pressure readings, and your own reports, and coordinates with psychiatrists, therapists, and other clinicians as needed.

Pricing: With insurance, sessions run $54 to $75. Self-pay sessions run $83 to $125, with no surprise clinic fees.

Program outcomes: Across Innerwell patients, 69% see a reduction in depression symptoms and 60% in anxiety symptoms over 10 weeks, and 87% notice improvement within the first four weeks.

Is ketamine therapy for depression right for me?

If part of you is thinking "I'm too old for this" or "I don't want to be a burden," that feeling deserves a direct answer. You aren't too old to pursue relief from depression that hasn't responded to anything else, and arranging help with transportation and monitoring is practical planning, not an imposition.

You're most likely to be a good fit if your depression resisted earlier antidepressants, your heart health is stable, and someone can be with you during sessions, a profile that fits many adults in their late 60s and early 70s. Intolerable side effects from current medications, like falls or confusion, can also make ketamine worth considering.

The cardiovascular and medication cautions above still apply, and a personal history of psychosis or bipolar disorder raises additional concerns. If you're 75 or older, the evidence for benefit is weaker, which makes a careful, honest evaluation especially important.

Try ketamine therapy for depression with Innerwell

When medication after medication hasn't worked, ketamine therapy offers a different path, one that can begin working within hours rather than weeks when paired with the right therapeutic support. With Innerwell, you get licensed clinicians, sublingual ketamine delivered to your home, therapy sessions, and monitoring throughout. Every step accounts for the medications you take and the safety risks that matter most at your age.

Take our free assessment to find the right treatment path for your situation.

Frequently Asked Questions

Who stays with me or my parent after treatment?

Someone you trust needs to be present for every session and able to drive afterward; you shouldn't drive until the next day. During the first four weeks of twice-weekly sessions, that means lining up support about eight times. Innerwell's team maps this out with you during the evaluation.

Is ketamine therapy for elderly depression legal?

Yes. Ketamine is an FDA-approved Schedule III medication, and Spravato (esketamine) is FDA-approved for treatment-resistant depression in adults. Licensed clinicians prescribe sublingual ketamine for depression off-label. Innerwell's care follows applicable telehealth laws, including state-location rules and privacy protections, to support safe, regulated treatment.

Is ketamine therapy for elderly depression covered by insurance?

Coverage is complicated for older adults. No uniform Medicare policy covers Spravato, and coverage varies by region. Most plans don't cover sublingual ketamine because it's off-label. Innerwell offers flat, transparent per-session pricing and can walk you through your options during the evaluation, and you can read more about treatment costs.